Skip to main content
Home
  • Solutions
    Clinical solutions
    Blended Solutions Cardiac Safety Solutions Clinical & Scientific Operations Decentralised Clinical Trials Early Clinical Laboratories Medical Imaging Site & Patient Solutions Strategic Solutions
    Consulting & Commercial
    Asset Development Consulting Commercial Positioning Language Services Outcome Measures Real World Intelligence Regulatory Affairs Symphony Health data
    meeting
    Case studies

    Reducing time to market, delivering on quality, providing deep therapeutic expertise and enhancing R&D ROI.

    Innovative research tools showcase
    Technologies

    Technology solutions from early phase through to post-marketing.

  • Sectors
    Sectors

    ICON provides its full range of clinical, consulting and commercial services across several industry sectors.

    Read more
    Biotech Government and Public Health Medical Device Pharmaceuticals
    Biotechnology services navigation panel
    Biotech

    Developing transformative therapies requires a flexible approach.

    Employee engagement program overview
    ICON and You

    Partners making a difference.

  • Therapeutics
    Therapeutics
    Cardiovascular Central Nervous System Endocrine & Metabolic Disorders Hepatology Infectious Diseases Internal Medicine & Immunology Oncology
    Cross-therapeutics
    Biosimilars Cell and Gene Therapies Medical Device Pediatrics Rare & Orphan Diseases Vaccines Women's Health
    Obesity 2025 insights image
    Obesity

    A focus on combination therapies requires appropriate obesity-specific trial designs, long-term follow-up studies and diverse patient recruitment.

    Biological research visual element
    Therapeutics insights

    ICON's therapeutic experts contribute regularly to industry publications and the creation of thought leadership content. Read more.

  • Insights
    Insights
    Digital Disruption Patient Centricity Regulatory Intelligence Therapeutics insights Transforming Trials Value Based Healthcare Blog Videos Webinar Channel
    thumbnail
    Making sense of the rapidly changing biosimilars landscape

    Strategies for adapting and achieving optimal market access

    thumbnail
    Building a comparative evidence base using network meta-analysis

    Methods, implementation and reporting

    banners
    From bottlenecks to breakthroughs

    Human-centred strategies for faster study starts

  • News & Events
    News & Events

    ICON regularly contributes thought leadership to industry media publications and conferences, and has been recognised as one of the world’s leading Contract Research Organisations through a number of high-profile industry awards.

    Read more
    Press releases In the News Mediakit Awards Events Webinars Social media
    Bioanalytical laboratory documentation
    Panel discussion: Flow cytometry in bioanalysis

    26 March 2026. Register today.

    thumbnail
    ICH GCP E6(R3): Preparing for global implementation, assessing the impact, risk and requirements of the change

    Watch the webinar.

  • About ICON
    About ICON
    Company history ICON at a glance ICON in Asia Pacific ICON in Latin America Leadership Quality
    ICON for
    Patients Volunteers Investigators Jobs & Careers Investors Suppliers
    Responsible business practice indicators
    Sustainability, charity, inclusion and belonging

    ICON Cares is our commitment to making a positive impact on our people, environment and our community.

    Modern reception area at Dublin office
    ICON at a glance

    Delivering successful outcomes across the clinical development lifecycle.

  • Careers
  • Investors
  • Contact
  • 日本語
  • 简体中文
  1. Home
  2. News & Events
  3. Social media

Social media

Page tools
Share Share
Facebook

Share on Facebook

Facebook

Share on X

Facebook

Share on Linkedin

Bluesky

Share on Bluesky

Showing 433 - 444 of 1038 results for "*"

ICON Plc facebook post
ICON Plc logo
ICON Plc

ICH GCP E6(R3): The Future Starts Now The final version of ICH GCP E6(R3) is here—and it’s changing the way we design and conduct clinical trials. ICON’s regulatory experts will guide you through what’s new, what’s crit...

24 Nov
3
View post
View webpage
Social media image
ICON Plc logo
ICON Plc

ICH GCP E6(R3) is here. Are you ready to lead the change? The global clinical research landscape is evolving and ICON is at the forefront. Join our upcoming Xtalks webinar to explore the impact, assess the risk and defi...

24 Nov
View post
View webpage
Social media image
ICON Plc logo
ICON Plc

In today’s data-rich healthcare landscape, open claims datasets offer unmatched breadth and timeliness. But disruptions—whether from new sources or supplier exits—are inevitable. Join Symphony Health, an ICON plc compan...

24 Nov
View post
View webpage
ICON Plc facebook post
ICON Plc logo
ICON Plc

Open claims datasets are a goldmine for life sciences—but they come with inevitable disruptions. Whether it’s new data sources or supplier exits, knowing how to manage change is key to maintaining strategic advantage. J...

24 Nov
2
View post
View webpage
ICON Plc facebook post
ICON Plc logo
ICON Plc

Join ICON for “Science on Tap” — an evening of discovery, discussion, and holiday cheer! Explore cutting-edge research in precision medicine and bioanalytical laboratory innovation with our expert scientists. If you ar...

21 Nov
2
View post
View webpage
Social media image
ICON Plc logo
ICON Plc

Join ICON for “Science on Tap” — an evening of discovery, discussion, and holiday cheer! Explore cutting-edge research in precision medicine and bioanalytical laboratory innovation with our expert scientists. If you ar...

21 Nov
View post
View webpage
ICON Plc facebook post
ICON Plc logo
ICON Plc

18-24 November is of World Antimicrobial Awareness Week. It is estimated that antibiotic resistance could cause 10 million deaths annually by 2050. Learn how ICON is taking action by supporting clinical research across a...

21 Nov
3
View post
View webpage
Social media image
ICON Plc logo
ICON Plc

As we mark World Antimicrobial Awareness Week, it’s time to spotlight innovative solutions to AMR. ICON’s article examines bacteriophage therapy and its potential to fight multidrug-resistant infections. Learn more: htt...

21 Nov
View post
View webpage
Social media image
ICON Plc logo
ICON Plc

As you plan your remaining 2025 budget, consider unlocking the power of Social Determinants of Health (SDoH) for smarter strategies that can transform your approach. Symphony Health, an ICON plc company’s SDoH dataset a...

21 Nov
View post
View webpage
ICON Plc facebook post
ICON Plc logo
ICON Plc

As you finalise your 2025 budget, consider adding Social Determinants of Health (SDoH) from Symphony Health, an ICON plc company. SDoH provides social, economic, and environmental context to patient-level data—helping y...

21 Nov
2
View post
View webpage
ICON Plc facebook post
ICON Plc logo
ICON Plc

Pregnant women are still largely excluded from clinical trials—leaving critical data gaps. ICON’s Liz O’Brien emphasises the need for trust, transparency, and education to safely include this population in research. Rea...

20 Nov
3
View post
View webpage
Social media image
ICON Plc logo
ICON Plc

Approximately 11% of sites failing to recruit a single patient. Visit us at #ASH25, booth \#2161 to learn about One Search, ICON’s award winning, AI-driven site selection tool to help identify the right sites the first t...

20 Nov
View post
View webpage
  • Previous
  • 1
  • …
  • 36
  • 37
  • 38
  • …
  • 87
  • Next
Filter by:

Filter by:

Site Branding
    ICON plc
  • Contact
  • About ICON
  • Results & Reports
For Clients
  • Therapeutics
  • Solutions
  • Insights
  • Technologies
  • Content preferences
  • Office locations
ICON for
  • Patients
  • Volunteers
  • Investigators
  • Jobs & Careers
  • Investors
  • Suppliers
News & Events
  • Press releases
  • Mediakit
  • Events
  • Webinars
Socials
  • Linkedin
  • Facebook
  • Instagram
  • Youtube

Legal Footer

  • © 2026 ICON plc
  • Disclaimer
  • Privacy & Data
  • Cookies
How can we help?
  • All
  • Website
Popular search terms:
  • Biotech
  • Cell and Gene Therapies
  • Consulting
  • Early Clinical
  • Medical Device
  • Oncology
  • Rare & Orphan Diseases
  • Real World Evidence
  • Site & Patient Recruitment
  • Strategic Solutions
  • Regulatory Intelligence